| Characteristics | Peripheral arterial disease | ||
| Yes (n = 25) | No (n = 28) | p-value | |
| Age (years) | 52.52 ± 15.08 | 46.14 ± 14.89 | 0.1278 |
| Female gender (%) | 16 (64%) | 15 (53.6%) | 0.2209 |
| Duration of dialysis (years) | 4.15 ± 2.38 | 4.32 ± 3.33 | 0.8334 |
| Diabetes | 1 (4%) | 1 (3.57%) | 0.4674 |
| Stroke | 2 (8%) | 2 (7.15%) | 0.4165 |
| Coronary artery disease | 0 | 1 (3.57%) | - |
| Cause of ESRD (%) |
|
|
|
| Hypertension | 13 (52%) | 14 (50%) | 0.4422 |
| Glomerulonephritis | 3 (12%) | 5 (17.85%) | 0.2761 |
| Polycystic kidney disease | 1 (4%) | 3 (10.7%) | 0.1778 |
| Diabetes mellitus | 1 (4%) | 0 | - |
| Others diagnoses | 2 (8%) | 4 (14.3%) | 0.2572 |
| Unknown | 5 (20%) | 2 (7.15%) | 0.1004 |
| Height (cm) | 168.12 ± 10.12 | 170.17 ± 8.63 | 0.4298 |
| Weight (Kg) | 62.54 ± 15 | 61.60 ± 13.87 | 0.8136 |
| BMI (kg/m²) | 21.88 ± 3.75 | 21.10 ± 3.66 | 0.4474 |
| Inter-dialytic weight gain (Kg) | 2.08 ± 0.88 | 2.31 ± 0.72 | 0.3006 |
| Smoking status |
|
|
|
| Current smoker (%) | 0 | 0 | - |
| Former smokers (%) | 6 (24%) | 5 (17.85%) | 0.3012 |
| Tobacco (packs/year) | 14.5 ± 20.91 | 14.2 ± 14.93 | 0.9792 |
| Pre-dialysis blood pressure (mmHg) |
|
|
|
| Systolic BP | 137.76 ± 19.08 | 142.07 ± 19.84 | 0.4252 |
| Diastolic BP | 78.12 ± 11.04 | 84.39 ± 10.43 | 0.0384 |
| PP | 59.64 ± 14.86 | 57.67 ± 12.61 | 0.6039 |
| MAP | 97.96 ± 12.46 | 103.64 ± 13.01 | 0.1117 |
| Post-dialysis blood pressure (mmHg) |
|
|
|
| Systolic BP | 135.12 ± 21.76 | 141.67 ± 23.29 | 0.2968 |
| Diastolic BP | 75.44 ± 10.18 | 81.96 ± 12.58 | 0.0447 |
| PP | 59.68 ± 16.36 | 59.71 ± 14.63 | 0.9944 |
| MAP | 95.32 ± 13.01 | 101.89 ± 15.44 | 0.1022 |
| Antihypertensive medications, n (%) |
|
|
|
| RAAS blockers use | 21 (75%) | 20 (80%) | 0.3321 |
| Calcium channel blocker use | 12 (48%) | 15 (53.6%) | 0.3484 |
| β-blockers use | 14 (50%) | 14 (56%) | 0.3373 |
| Statins use | 7 (28%) | 6 (21.43%) | 0.2986 |
| Aspirin use | 5 (20%) | 7 (25%) | 0.3417 |
| ABI | 0.78 ± 0.08 | 1.06 ± 0.10 | <0.0001 |